Written Exposure Therapy for Post-Traumatic Stress Disorder
Trial Summary
Will I have to stop taking my current medications?
You can continue taking your current medications if they are psychotropic (affecting the mind) and you have been on a stable dose for at least 4 weeks before the study. You must also agree to keep the dosage stable during the study.
What data supports the effectiveness of the treatment Written Exposure Therapy (WET) for Post-Traumatic Stress Disorder?
Research shows that Written Exposure Therapy (WET) is effective for treating PTSD, with significant symptom improvement in patients, including veterans. It is a brief treatment that has been found to be as effective as longer therapies like Cognitive Processing Therapy, with benefits lasting up to 60 weeks.12345
Is Written Exposure Therapy (WET) safe for humans?
How is Written Exposure Therapy different from other PTSD treatments?
What is the purpose of this trial?
Mental contamination-an internal experience of dirtiness evoked in the absence of physical contact with an external source-has been linked to the development and maintenance of posttraumatic stress disorder (PTSD) following exposure to sexual abuse or assault (Adams et al., 2014; Badour et al., 2013; Brake et al., 2017). Mental contamination has been associated with greater PTSD severity (Rachman et al., 2015) and higher elevations in specific PTSD symptom clusters (particularly those of intrusive re-experiencing, negative cognitions/mood, and arousal/reactivity; Brake et al., 2019; Fergus \& Bardeen, 2016). Additionally, trauma-related mental contamination has been linked to a number of negative posttraumatic emotions such as shame, guilt, disgust, and anger (Fairbrother \& Rachman, 2004; Radomsky \& Elliott, 2009). Despite clear and consistent links between mental contamination and problematic posttraumatic outcomes following sexual trauma, there is a dearth of research investigating how existing or promising new interventions for PTSD impact mental contamination.Written Exposure Therapy (WET) is a five-session treatment for PTSD that was designed to be both brief and easy to administer (Sloan et al., 2012). According to Sloan and colleagues' (2012) protocol, sessions broadly involve 30-minute exposures in which the patient writes about the events of their trauma in detail, followed by 10 minutes of discussing the exposure with the therapist. This treatment protocol has minimal therapist involvement, no homework assignments, and shorter treatment sessions. Research shows that WET is efficacious among different samples (e.g., survivors of motor vehicle accidents and combat veterans), has low dropout rates, treatment satisfaction is high, and the gains seen by participants after completion are maintained at follow-up (Sloan et al., 2012, 2013, 2018; Thompson-Hollands et al., 2018, 2019). Given these factors, WET has the potential to be a useful intervention in reducing symptoms of PTSD among a sample of survivors of sexual trauma. Given its relevance to this trauma population, a test of this intervention for its impact on reducing trauma-related mental contamination is also needed.The current study will use Single Case Experimental Design to isolate and evaluate the effects of WET in reducing both PTSD symptoms and trauma-related mental contamination among individuals with PTSD resulting from sexual trauma.Aims: Explore whether participants demonstrate reductions in mental contamination and PTSD symptoms in response to 5 sessions of WET. Visual inspection analysis and statistical methods will be used to draw conclusions regarding the effects of the interventions on PTSD symptoms and mental contamination.
Research Team
Christal L Badour, PhD
Principal Investigator
University of Kentucky
Jesse McCann, MS
Principal Investigator
University of Kentucky
Eligibility Criteria
This trial is for adults who have experienced sexual trauma, can read and write in English, and are currently dealing with PTSD symptoms and mental contamination. They must not be starting new trauma-related treatments or changing their stable psychotropic medication doses during the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants complete weekly assessments of PTSD symptoms and mental contamination
Treatment
Participants receive 5 weekly sessions of Written Exposure Therapy (WET)
Follow-up
Participants are monitored for changes in PTSD symptoms and mental contamination
Treatment Details
Interventions
- Written Exposure Therapy
Written Exposure Therapy is already approved in United States for the following indications:
- Post-Traumatic Stress Disorder (PTSD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jesse McCann
Lead Sponsor